Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty
Primary Purpose
Osteoarthritis, Arthroplasty
Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Ropivacaine with NaCl
Epinephrine
Morphine
Ketorolac Tromethamine
Ropivacaine
Sponsored by

About this trial
This is an interventional treatment trial for Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing unilateral primary total hip arthroplasty by Dr. James Verner at Beaumont Hospital Royal Oak
- Have a diagnosis of primary osteoarthritis (i.e. degenerative joint disease)
- Surgical approach is anterior
Exclusion Criteria:
- Minors (age less than 18 years)
- Pregnant (surgically sterile, post-menopausal, or negative blood test)
- Previous ipsilateral hip surgery
- Lumbar instrumentation
- Acute trauma
- Rheumatoid arthritis
- Avascular necrosis
- Hip dysplasia
- Known sensitivity, allergy, or contraindication to anesthetics being used in the study
- Narcotic sensitivity
- History of over 6 months of opioid dependency prior to surgery (excluding tramadol)
- Peripheral neuropathy
- Mental/cognitive impairment that would interfere with the patient's self-assessments of function, pain, or quality of life
Sites / Locations
- Beaumont Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Psoas Compartment Block
Periarticular Local Anesthetic
Arm Description
After exposure anesthetic (Ropivacaine with NaCl) is introduced directly into the iliopsoas muscle, where it then spreads to the lumbar plexus (the nerves responsible for sensation around the surgical site).
An anesthetic "cocktail" of four drugs (ropivacaine, epinephrine, ketorolac tromethamine, morphine) is injected at five locations at the surgical site to the surrounding tissues.
Outcomes
Primary Outcome Measures
Pain Score at 3 Hours
Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain
Secondary Outcome Measures
Pain Score at 3-24 Hours
Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain
Pain Score at 24-48 Hours
Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain
Opioid Usage In-hospital at 24 Hours
Total amount of opioids used per patient (measured with Morphine Equivalent Units)
Opioid Usage In-hospital at 48 Hours
Total amount of opioids used per patient (measured with Morphine Equivalent Units)
Full Information
NCT ID
NCT02658149
First Posted
January 14, 2016
Last Updated
April 9, 2018
Sponsor
William Beaumont Hospitals
1. Study Identification
Unique Protocol Identification Number
NCT02658149
Brief Title
Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty
Official Title
Psoas Compartment Block Versus Periarticular Local Anesthetic Infiltration for Pain Management for Total Hip Arthroplasty: A Prospective, Randomized Study
Study Type
Interventional
2. Study Status
Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
May 2016 (undefined)
Primary Completion Date
May 11, 2017 (Actual)
Study Completion Date
June 2, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
William Beaumont Hospitals
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The primary objective of this study is to examine whether there is a difference in the level of resting pain following total hip arthroplasty with an anterior approach with use of a psoas compartment block versus a local periarticular anesthetic infiltration
Detailed Description
A single-center, prospective, randomized clinical trial with a total of 100 patients. One orthopaedic adult reconstruction surgeon at Beaumont Hospital Royal Oak (JJV) will perform all surgeries. After the patient has consented they will be randomized to one of the following two groups:
Psoas compartment block (n=50)
Periarticular local anesthetic infiltration (n=50),
The patient will be blinded to the study group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Arthroplasty
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Psoas Compartment Block
Arm Type
Experimental
Arm Description
After exposure anesthetic (Ropivacaine with NaCl) is introduced directly into the iliopsoas muscle, where it then spreads to the lumbar plexus (the nerves responsible for sensation around the surgical site).
Arm Title
Periarticular Local Anesthetic
Arm Type
Active Comparator
Arm Description
An anesthetic "cocktail" of four drugs (ropivacaine, epinephrine, ketorolac tromethamine, morphine) is injected at five locations at the surgical site to the surrounding tissues.
Intervention Type
Drug
Intervention Name(s)
Ropivacaine with NaCl
Other Intervention Name(s)
Naropin with NaCl
Intervention Description
50 mL (40 mL of 0.2% Ropivicaine and 10 mL of 0.9% NaCl) are administered into the psoas compartment
Intervention Type
Drug
Intervention Name(s)
Epinephrine
Other Intervention Name(s)
adrenaline
Intervention Description
0.15 mg Epinephrine are injected as part of the drug "cocktail"
Intervention Type
Drug
Intervention Name(s)
Morphine
Intervention Description
4 mg Morphine are injected as part of the drug "cocktail"
Intervention Type
Drug
Intervention Name(s)
Ketorolac Tromethamine
Other Intervention Name(s)
Toradol
Intervention Description
30 mg morphine are injected as part of the drug "cocktail"
Intervention Type
Drug
Intervention Name(s)
Ropivacaine
Other Intervention Name(s)
Naropin
Intervention Description
30 mL 0.5% Ropivicaine are injected as part of the drug "cocktail"
Primary Outcome Measure Information:
Title
Pain Score at 3 Hours
Description
Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain
Time Frame
3 hours postoperative
Secondary Outcome Measure Information:
Title
Pain Score at 3-24 Hours
Description
Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain
Time Frame
measured once during time frame 3 hours-24 hours postoperative
Title
Pain Score at 24-48 Hours
Description
Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain
Time Frame
measured once during time froma 24-48 hours postoperative
Title
Opioid Usage In-hospital at 24 Hours
Description
Total amount of opioids used per patient (measured with Morphine Equivalent Units)
Time Frame
24 hours postoperatively
Title
Opioid Usage In-hospital at 48 Hours
Description
Total amount of opioids used per patient (measured with Morphine Equivalent Units)
Time Frame
48 hours postoperatively
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing unilateral primary total hip arthroplasty by Dr. James Verner at Beaumont Hospital Royal Oak
Have a diagnosis of primary osteoarthritis (i.e. degenerative joint disease)
Surgical approach is anterior
Exclusion Criteria:
Minors (age less than 18 years)
Pregnant (surgically sterile, post-menopausal, or negative blood test)
Previous ipsilateral hip surgery
Lumbar instrumentation
Acute trauma
Rheumatoid arthritis
Avascular necrosis
Hip dysplasia
Known sensitivity, allergy, or contraindication to anesthetics being used in the study
Narcotic sensitivity
History of over 6 months of opioid dependency prior to surgery (excluding tramadol)
Peripheral neuropathy
Mental/cognitive impairment that would interfere with the patient's self-assessments of function, pain, or quality of life
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James Verner, MD
Organizational Affiliation
William Beaumont Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Beaumont Hospital
City
Royal Oak
State/Province
Michigan
ZIP/Postal Code
48073
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty
We'll reach out to this number within 24 hrs